Glutathione vs NMN: Simple Comparison for Curious Readers
Two Molecules, Two Very Different Jobs
You've probably seen both names on supplement shelves. But Glutathione and NMN work in completely different ways. Let's break each one down before comparing them side by side.
What Is Glutathione?
Glutathione is a tiny protein-like molecule made from three amino acids. Your cells produce it naturally. Scientists call it the body's "master antioxidant" because it neutralises harmful molecules called free radicals and helps recycle other antioxidants like vitamin C. Levels tend to fall as we get older, and researchers are studying whether topping them back up has measurable benefits.
What Is NMN?
NMN stands for Nicotinamide Mononucleotide. That's a mouthful — think of it as a raw ingredient your cells use to build NAD+. NAD+ (nicotinamide adenine dinucleotide) is a molecule involved in hundreds of reactions that keep cells energised and DNA repaired. The key point: NAD+ levels drop significantly with age.[1] NMN is one way researchers are trying to restore them.
What Does the Research Say?
NMN in Animal Studies
A landmark 12-month mouse study found that daily oral NMN prevented age-related body weight gain, improved energy metabolism, and boosted physical activity — all without obvious toxic effects.[2] A more recent preprint reported that long-term NMN increased both lifespan and healthspan in mice, though effects varied by sex.[6] Animal data is promising, but it doesn't automatically translate to humans.
NMN in Human Trials
Human research is catching up fast. A double-blind clinical trial in healthy middle-aged adults tested 300 mg, 600 mg, and 900 mg of NMN daily for 60 days. Blood NAD+ rose significantly in all treated groups. Walking performance improved, and self-reported health scores were better than placebo — with no safety concerns flagged.[3] A broader review of human clinical trials concluded NMN appears safe and well-tolerated, though larger and longer studies are still needed.[1] Researchers have also noted there are safety questions that future trials must answer more thoroughly.[4]
Glutathione in Research
Glutathione research has a longer history. Studies have explored both oral and intravenous forms. Because the molecule can break down in the gut, many researchers use a stabilised form called "liposomal" glutathione or look at precursors like NAC (N-acetyl cysteine) that help the body make more of its own. Doses in published trials range widely — typically from 250 mg to over 1,000 mg per day depending on the outcome being studied. You can explore those ranges on our Glutathione chart page.
Quick Side-by-Side Comparison
- Primary role: Glutathione = antioxidant defence; NMN = NAD+ precursor for energy and DNA repair
- Made by the body? Both are produced naturally; both decline with age
- Research dose range: Glutathione ~250–1,000+ mg/day in trials; NMN ~100–900 mg/day in human studies[3]
- Human trial maturity: Glutathione has a longer human research history; NMN human trials are newer but growing fast[1]
- Delivery challenge: Glutathione degrades in the gut (liposomal forms help); NMN appears well-absorbed orally[4]
- Studied in reproductive health? NMN has been researched for age-related egg quality in animal models[5]; Glutathione has separate reproductive research tracks
How to Choose What to Read About
Neither molecule is "better" — they do different things. The smarter question is: which research question interests you most?
If you're curious about antioxidant pathways, cellular detox, or immune support, Glutathione research is the place to start. If age-related energy metabolism, NAD+ biology, or metabolic health is your focus, dive into the NMN literature.
Either way, dose context matters enormously when reading a study. A result seen at 900 mg/day in a clinical trial doesn't tell you much about 100 mg. Use our calculator to put research doses in perspective before drawing any conclusions.
The Bottom Line
Glutathione and NMN are both serious subjects of ongoing scientific research. The studies are real, the mechanisms are biologically plausible, and the dose data is getting richer every year.[1][3] Neither has a complete human evidence base yet — that's precisely why reading the primary research carefully, with dose numbers in hand, is so valuable. This content is for educational purposes only and is not medical advice.
Sources
- The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. — Advances in nutrition (Bethesda, Md.), 2023. PMID 37619764.
- Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. — Cell metabolism, 2016. PMID 28068222.
- The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. — GeroScience, 2023. PMID 36482258.
- Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns. — Journal of advanced research, 2022. PMID 35499054.
- Nicotinamide Mononucleotide Supplementation Reverses the Declining Quality of Maternally Aged Oocytes. — Cell reports, 2020. PMID 32755581.
- Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner. — bioRxiv : the preprint server for biology, 2024. PMID 38979132.